Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery | Last updated: August 30, 2026
Key Takeaways
- Conventional DMARDs and biologics currently have the strongest human evidence for autoimmune management, with network meta-analyses confirming superiority over placebo for ACR50 response.
- Gut-repair protocols and probiotic supplementation rank second in evidence strength and reduce inflammatory markers like IL-6, TNF-α, and hs-CRP in randomized trials.1
- Many patients can reach meaningful remission with functional medicine, although complete immunological reversal remains unlikely because immune memory is permanent.1
- Elimination diets such as the Autoimmune Protocol often identify gluten, processed foods, nightshades, and dairy as the most frequent dietary triggers for autoimmune flares.
- Patients who want personalized autoimmune care can book a consultation with Mirror Plastic Surgery to review labs and explore evidence-based treatment options.
Top Evidence-Backed Autoimmune Options Available in Tampa Bay
Three main intervention categories carry the most substantial human data for autoimmune management in 2026.
Conventional DMARDs and biologic agents sit at the highest evidence tier. A 2026 network meta-analysis of 16 phase 2/3 randomized controlled trials in psoriatic arthritis found all active treatments, including IL-17 inhibitors, superior to placebo for ACR50 response at weeks 12–16. Certainty via CINeMA ranged from very low to high. A separate 2026 meta-analysis of immunosuppressive therapy reported high overall response rates. Rheumatologists direct these therapies, and they are FDA-approved.
Gut-repair and probiotic protocols form a strong second tier. A 2026 systematic review and meta-analysis of 12 randomized controlled trials involving 703 autoimmune patients found that oral probiotic supplementation produced significant reductions in IL-6, TNF-α, and hs-CRP versus controls. Effects were most pronounced in rheumatoid arthritis and multiple sclerosis subgroups.
IV antioxidant and ozone-based therapies represent a third, more exploratory tier. Medical ozone at moderate concentrations may shift immune responses from pro-inflammatory Th1/Th17 dominance toward a more balanced state. Overall evidence remains preliminary, so these approaches work best as complements to established care rather than replacements.
Autoimmune Reversal vs. Remission: What Current Evidence Shows
Complete immunological reversal remains unlikely because immune memory persists for life. Many patients can still achieve meaningful remission. Functional medicine can reduce disease activity, lower antibody titers, extend remission, reduce flare frequency, and allow medication reduction, especially when treatment begins before irreversible tissue damage develops.
Realistic timelines based on current evidence follow a predictable sequence, with inflammatory markers responding first and antibody changes arriving later.
- hs-CRP and ESR reductions are typically measurable within 3 months when environmental triggers are addressed, so they serve as early indicators of progress.1
- Anti-TPO antibodies may begin declining by months 2–3 with selenium supplementation, while gut barrier trends usually improve between months 3 and 6.1
- Full remission, when achievable, typically requires 12 to 24 months of consistent functional medicine work.1 Many patients report their strongest gains around the 18‑month mark as earlier improvements accumulate.
- The IFM 2026 Outcomes Registry reports 23% of Hashimoto’s patients achieved sustained remission when working with certified practitioners for 18 or more months, which supports this longer-term timeline.1
Experimental cell-based therapies such as CAR-T are producing functional cure results in small refractory-disease trials. These therapies remain investigational and do not yet apply to the broader autoimmune population.
While advanced therapies continue to develop, most patients can act now by focusing on diet and gut health. Dietary changes often provide the most immediate, practical lever for reducing flares and supporting remission.
Major Diet Triggers for Autoimmune Flares
Elimination-diet research consistently highlights a core group of dietary triggers. The Autoimmune Protocol (AIP) removes these foods for 30–60 days to support gut barrier healing and immune recalibration.
In a 2019 survey of 78 individuals with IBD who self-implemented AIP, the most commonly identified trigger foods during reintroduction were:
- Gluten, reported by 58% of participants
- Processed foods, reported by 52%
- Nightshades, reported by 46%
- Dairy, reported by 42%
Evidence does not support a consistent 40–50% reduction in TPO antibodies from gluten elimination in celiac or Hashimoto’s overlap patients. Available meta-analyses show non-significant trends or even increases in antibody levels. A 2019 study of 17 women with Hashimoto’s thyroiditis found that a 10‑week AIP intervention reduced Medical Symptom Questionnaire scores from 92 to 29 and lowered hs-CRP by 29%. A 2026 open-label trial in chronic inflammatory arthritis patients reported that short-term high-fiber supplementation increased short-chain fatty acid levels, shifted gut microbiota toward saccharolytic taxa, and reduced circulating inflammatory mediators.
Biomarker Testing Panels Tampa Specialists Commonly Use
Foundational first-line panel applies to any patient with suspected autoimmune activity.
- ANA (with titer and pattern), RF, anti-CCP, anti-TPO, anti-TG, ESR, hs-CRP, ferritin, and vitamin D
- Full thyroid panel (TSH, free T3, free T4, TPO, TgAb), CBC, CMP, and ferritin
Second-line and disease-specific markers come into play when screening suggests a particular condition.
- Anti-dsDNA, anti-Smith, anti-SSA/SSB, and complement C3/C4 when ANA titer is 1:160 or higher with symptoms
- Fecal calprotectin levels above 250 μg/g indicate likely active inflammation in IBD, while levels below 50–100 μg/g suggest quiescent disease or mucosal healing.
- Nutrient status markers including zinc, selenium, magnesium, and omega-3 index, plus comprehensive stool analysis with secretory IgA
Retesting intervals: Foundational panels are typically retested every 3 to 6 months after initiating treatment, while disease-specific antibodies such as TPO or anti-CCP are monitored at 6 to 12 month intervals.
Comparing DMARDs, Gut Protocols, IV Therapies, and Lifestyle Interventions
Once you have baseline labs, the next step is choosing which intervention to prioritize. The comparison below ranks each modality by evidence strength, expected timeline, and ideal patient profile so you can match your situation to a realistic starting point.
| Modality | Strength of Human Evidence | Typical Timeline to Measurable Effect | Best Suited For |
|---|---|---|---|
| Conventional DMARDs / Biologics | Network meta-analysis evidence, with all active treatments including IL-17 inhibitors superior to placebo for ACR50 at weeks 12–16 and CINeMA certainty ranging from very low to high | Weeks 12–16 for biologic response in psoriatic arthritis trials | Moderate-to-severe diagnosed autoimmune disease, rheumatologist-directed |
| Gut-Repair / Probiotic Protocols | Moderate evidence from 12 RCTs and 703 patients showing significant inflammatory marker reductions | Three to six months for intestinal barrier restoration | IBD, Hashimoto’s, RA with gut involvement, used as an adjunct to standard care |
| AIP / Elimination Diet | Preliminary RCT and pilot data, with 73% IBD remission and 68% Hashimoto’s symptom remission in elimination phases | Four to six weeks for initial symptom relief, with full protocol spanning several months | IBD, Hashimoto’s, RA, and patients motivated for dietary change |
| IV Antioxidant / Ozone Therapy | Preliminary animal and early human data only, not FDA-approved for any autoimmune indication | Variable, with short-term joint pain improvements that narrow by 3–6 months in osteoarthritis trials | Complementary use only, not a replacement for established therapies |
How to Use Tampa Bay Functional Medicine Providers
After you understand your evidence-based options, choosing the right type of local provider becomes easier. Each practice style in Tampa Bay offers different strengths for testing, coaching, and ongoing support.
Local functional medicine practices focus on comprehensive functional evaluations that include thyroid antibody panels, adrenal testing, and gut microbiome assessments. Many of these practices also provide IV nutrient therapy and ozone-based treatments alongside dietary interventions, which suits patients exploring multiple modalities at once.
Integrative wellness centers emphasize root-cause functional medicine with detailed first-line and second-line autoimmune panels. They often pair AIP dietary coaching with microbiome testing, including stool analysis with secretory IgA, which works well for patients who want structured nutrition support.
Integrative health practices typically offer biomarker-guided protocols, hormone and nutrient panels, and lifestyle-based autoimmune management programs. They usually schedule retesting every 3 to 6 months, which helps patients track progress and adjust plans over time.
Wellness centers provide foundational autoimmune screening panels, gut-repair protocols, and nutritional counseling. Many coordinate care with rheumatology and endocrinology, which benefits patients who already work with specialists and want added lifestyle guidance.
Decision Guide: Standard Care, Functional Medicine, and Peptides
| Patient Situation | Recommended Starting Point | Functional Medicine Add-On | Consider Supervised Peptides When |
|---|---|---|---|
| Newly diagnosed, moderate-to-severe symptoms | Rheumatologist for DMARD or biologic evaluation | AIP diet, probiotic protocol, foundational labs | Stable on standard care and seeking adjunct anti-inflammatory support |
| Mild symptoms, no prior workup | Foundational biomarker panel with primary care or functional medicine | Elimination diet, gut-repair protocol, targeted nutrient support | After 3–6 months of dietary and lifestyle intervention with incomplete response |
| DMARD side effects or limited response | Rheumatologist reassessment and possible biologic switch | Microbiome testing, IV nutrient support, AIP | Within a lab-guided, medically supervised program that includes clear monitoring |
| Hashimoto’s or IBD in early stages | Full thyroid or IBD panel with endocrinology or gastroenterology referral | Selenium and vitamin D optimization, gluten elimination when appropriate | Antibody titers remain elevated after 6–12 months of functional protocol |
When Supervised Peptide Therapy Fits the Plan
Some patients complete a foundational biomarker workup, follow dietary and gut-repair protocols, and still experience persistent inflammation or only partial remission. For these individuals, medically supervised peptide therapy can serve as an additional evidence-informed option to review with a qualified provider.
Mirror Plastic Surgery’s peptide program, led by board-certified Family Nurse Practitioner Ellie Pranckevicius, FNP-BC, uses a concierge model that begins with in-depth lab analysis. This analysis includes inflammatory markers, thyroid panels, and metabolic markers before any protocol is designed. Peptides come from suppliers with documented batch testing. Ellie offers direct one-on-one support throughout the program, including telemedicine access and ongoing monitoring, rather than a single preset prescription.
As of 2026, the oral peptide icotrokinra has positive confirmatory Phase 3 trial evidence (ICONIC-LEAD) in moderate-to-severe plaque psoriasis. Peptide therapy for autoimmune conditions is not FDA-approved and should be considered only within a supervised, lab-guided framework after established modalities have been evaluated.
Frequently Asked Questions
How long does it realistically take to see results from functional medicine autoimmune treatment?
Most patients following a structured functional medicine protocol notice initial symptom changes within 4 to 6 weeks, especially in energy, digestive comfort, and pain.1 Inflammatory markers such as hs-CRP and ESR usually respond within the 3‑month window described earlier. Disease-specific antibodies such as TPO or anti-CCP are slower to shift and are generally monitored at 6 to 12 month intervals. Full remission, when achievable, often requires 12 to 24 months of consistent work. Timelines vary based on disease duration, prior tissue damage, and adherence to the plan.
What happens if I stop a peptide or functional medicine protocol and my symptoms return?
Stopping any active treatment, whether dietary, supplemental, or peptide-based, usually allows the underlying inflammatory process to resume if root causes remain. Many patients on AIP can reintroduce foods over time without triggering flares once gut barrier integrity improves. For peptide therapy, anti-inflammatory effects generally depend on continued use, so stopping without a maintenance plan often leads to a gradual return toward baseline inflammation. Well-designed programs include a tapering or maintenance phase and ongoing biomarker monitoring rather than an abrupt stop.
How do I evaluate any Tampa Bay provider offering autoimmune or peptide services?
A trustworthy provider will order or review a comprehensive baseline biomarker panel before recommending any protocol. They will explain the evidence level behind each recommendation, clarify which therapies are FDA-approved, and set realistic expectations about timelines and outcomes. For peptide services, ask about third-party batch testing, individualized dosing based on labs and history, and structured follow-up. Providers who skip lab review, offer a single protocol to everyone, or promise guaranteed reversal are not following evidence-based standards. Coordination with your rheumatologist, endocrinologist, or gastroenterologist is a positive sign.
Is the Autoimmune Protocol diet safe to try without medical supervision?
The AIP elimination phase is generally safe for most adults and does not rely on medications or high-risk supplements. Starting without baseline testing, however, leaves you without objective data to measure progress and may hide conditions that need medical treatment. Patients on immunosuppressive medications or biologics should not reduce or stop those drugs based on diet alone without rheumatology guidance. Working with a functional medicine practitioner or nurse practitioner who can order labs at baseline and at 3 to 6 month intervals provides a measurable framework for evaluating results and making adjustments.
Conclusion and Next Steps for Tampa Bay Autoimmune Care
Tampa Bay residents with autoimmune conditions have access to a wide range of evidence-ranked options. These include conventional DMARDs and biologics with the strongest human trial data, gut-repair and probiotic protocols with growing randomized support, AIP dietary interventions with consistent pilot-study results, and IV or ozone therapies as exploratory complements. Supervised peptide therapy remains a potential option for selected candidates after foundational approaches have been tried, but it requires lab-guided personalization and clear communication about its current evidence status.
The most effective path forward starts with a comprehensive biomarker panel, a clear understanding of your disease stage and prior treatment response, and a provider willing to coordinate across modalities instead of promoting a single approach.
Mirror Plastic Surgery is located at 780 4th Ave S, St. Petersburg, FL 33701. Reach the practice by phone or text at 727-361-6515 or by email at hello@mirrorplasticsurgery.com. Consultations are available in person and via telemedicine across Florida and the United States.
Disclaimer: Individual results vary and are not guaranteed. Peptide therapies discussed on this page are not FDA-approved for the treatment of autoimmune diseases. Nothing in this article constitutes medical advice or replaces consultation with a licensed healthcare provider. Always consult your physician or specialist before modifying any existing treatment plan.
1 Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.
